These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8415579)

  • 21. Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity.
    Kaczmarek E; Lee MH; McDonagh J
    J Biol Chem; 1993 Feb; 268(4):2474-9. PubMed ID: 8428923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator.
    Lubin IM; Caban R; Runge MS
    J Biol Chem; 1993 Mar; 268(8):5550-6. PubMed ID: 8449917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators.
    Toschi L; Bringmann P; Petri T; Donner P; Schleuning WD
    Eur J Biochem; 1998 Feb; 252(1):108-12. PubMed ID: 9523718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE; Will H
    Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.
    Verheijen JH; Caspers MP; Chang GT; de Munk GA; Pouwels PH; Enger-Valk BE
    EMBO J; 1986 Dec; 5(13):3525-30. PubMed ID: 3030730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gamma Gly-268 to Glu substitution is responsible for impaired fibrin assembly in a homozygous dysfibrinogen Kurashiki I.
    Niwa K; Takebe M; Sugo T; Kawata Y; Mimuro J; Asakura S; Sakata Y; Mizushima J; Maeda A; Endo H; Matsuda M
    Blood; 1996 Jun; 87(11):4686-94. PubMed ID: 8639838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
    Yakovlev S; Makogonenko E; Kurochkina N; Nieuwenhuizen W; Ingham K; Medved L
    Biochemistry; 2000 Dec; 39(51):15730-41. PubMed ID: 11123898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule.
    Urano T; Takada Y; Takada A
    Biochim Biophys Acta; 1991 Apr; 1077(3):245-52. PubMed ID: 1903067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of a novel chimeric truncated t-PA in CHO cells based on in silico experiments.
    Davami F; Sardari S; Majidzadeh-A K; Hemayatkar M; Barkhrdari F; Omidi M; Azami M; Adeli A; Davoudi N; Mahboudi F
    J Biomed Biotechnol; 2010; 2010():108159. PubMed ID: 20885932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.
    Fleury V; Loyau S; Lijnen HR; Nieuwenhuizen W; Anglés-Cano E
    Eur J Biochem; 1993 Sep; 216(2):549-56. PubMed ID: 8375393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a chimaeric plasminogen activator obtained by insertion of the second kringle structure of tissue-type plasminogen activator (amino acids 173 through 262) between residues Asp130 and Ser139 of urokinase-type plasminogen activator.
    Lijnen HR; Piérard L; Reff ME; Gheysen D
    Thromb Res; 1988 Dec; 52(5):431-41. PubMed ID: 3146822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot.
    Bakker AH; Weening-Verhoeff EJ; Verheijen JH
    J Biol Chem; 1995 May; 270(21):12355-60. PubMed ID: 7759476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of a novel chimeric tissue plasminogen activator with favorable Vampire bat plasminogen activator properties.
    Kazemali M; Majidzadeh-A K; Sardari S; Saadatirad AH; Khalaj V; Zarei N; Barkhordari F; Adeli A; Mahboudi F
    Enzyme Microb Technol; 2014 Dec; 67():82-6. PubMed ID: 25442953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A; Castellino FJ
    Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substrate specificity of tissue type plasminogen activator. Characterization of the fibrin independent specificity of t-PA for plasminogen.
    Madison EL; Coombs GS; Corey DR
    J Biol Chem; 1995 Mar; 270(13):7558-62. PubMed ID: 7706303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein loop grafting to construct a variant of tissue-type plasminogen activator that binds platelet integrin alpha IIb beta 3.
    Smith JW; Tachias K; Madison EL
    J Biol Chem; 1995 Dec; 270(51):30486-90. PubMed ID: 8530479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.